$500 – $1,000 Paid Clinical Trials

440 studies

Short outpatient Phase 1 studies and multi-visit observational studies often compensate in the $500–$1,000 range.

Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.

Showing 321–340 of 440 studies

$500 – $1,000 Paid Clinical Trials

Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants

A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Injection

A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

A Study to Assess the Safety of ARGX-213 in Healthy Volunteers

Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus

Comparative Study of EnliTuo® Before and After Technology Change in Healthy Male Volunteers

Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.

A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants

A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

A First-in-Human Single and Multiple Ascending Dose Study of MT-201

A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome

A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP